We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+8.05%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
AUM
$638M
AUM Growth
+$37.5M
Cap. Flow
-$628K
Cap. Flow %
-0.1%
Top 10 Hldgs %
26.89%
Holding
248
New
15
Increased
94
Reduced
104
Closed
9

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.6%
2 Healthcare 13.6%
3 Consumer Staples 11.74%
4 Technology 10.54%
5 Financials 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLE icon
226
State Street Energy Select Sector SPDR ETF
XLE
$41.2B
$202K 0.03%
+4,874
New +$201K
ALBO
227
DELISTED
Albireo Pharma Inc
ALBO
$202K 0.03%
2,135
+333
+18% +$43.4K
CRM icon
228
Salesforce
CRM
$211B
$200K 0.03%
+3,860
New +$175K
INFU icon
229
InfuSystem Holdings
INFU
$240M
$141K 0.02%
110,000
-5,000
-4% -$7.36K
CALY
230
Callaway Golf Company
CALY
$2.8B
$71K 0.01%
+10,000
New +$70.6K
DYSL
231
DELISTED
Dynasil Corporation of America
DYSL
$48K 0.01%
54,675
+13,021
+31% +$9.6K
LQMT
232
DELISTED
LIQUIDMETAL TECHNOLOGIES INC
LQMT
$26K ﹤0.01%
174,500
-8,156
-4% -$1.22K
CVE icon
233
Cenovus Energy
CVE
$58.2B
-8,160
Closed -$233K
EPC icon
234
Edgewell Personal Care
EPC
$1.34B
-2,751
Closed -$205K
FCX icon
235
Freeport-McMoran
FCX
$110B
-7,348
Closed -$203K
MUR icon
236
Murphy Oil
MUR
$5.11B
-4,487
Closed -$236K
PX
237
DELISTED
Praxair Inc
PX
-1,962
Closed -$226K
ACI
238
DELISTED
ARCH COAL, INC.
ACI
-1,065
Closed -$40K
NWSA
239
DELISTED
NEWS CORPORATION CL-A
NWSA
-33,930
Closed -$1.1M

Similar funds

Dowling & Yahnke's Q3 2013 Portfolio in Review

As of Q3 2013, Dowling & Yahnke held 248 positions worth $638M, up 6.2% from $601M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Dowling & Yahnke's Q3 2013 filing shows 15 new, 94 increased, 104 reduced and 9 closed positions. Its largest new stake was Pfizer: 199,922 shares worth $5.45M. The largest sale was Ionis Pharmaceuticals, an estimated $2.99M.

By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Dowling & Yahnke's largest Q3 2013 buy was Pfizer: 199,922 shares worth $5.45M.
  • Dowling & Yahnke added most to Leidos in Q3 2013, an estimated $3.34M increase.
  • Dowling & Yahnke's biggest Q3 2013 reduction was Ionis Pharmaceuticals, cutting an estimated $2.99M.
  • Dowling & Yahnke fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $1.1M.
  • Dowling & Yahnke's ten largest holdings make up 27% of its $638M portfolio in Q3 2013.
  • Dowling & Yahnke opened 15 new positions and closed 9 in Q3 2013.
  • Dowling & Yahnke's portfolio value rose 6.2% quarter-over-quarter to $638M.

Based on Dowling & Yahnke's 13F filing for Q3 2013, filed 12 Nov 2013.